Use case
Shape-based virtual screening
Prepare reference ligands and candidate conformers, compare three-dimensional shape and chemical features, then review a diverse shortlist in one connected workflow.
Inputs
2 required
Methods
5 connected
- 01PoseBusters · overlay geometry
- 02SDF to SMILES
- 03Molecular descriptors
- 04PAINS filter · review
- 05ADMET-AI
ProteinIQ does not yet provide a general query-shape library-screening engine. This runnable review template starts from the aligned SDF output of the validated shape method used by the program, checks overlay geometry against the reference ligand, and keeps downstream triage connected.
Use this templateWhat is shape-based virtual screening?
Shape-based virtual screening is a computational method for ranking candidate molecules by how closely their three-dimensional conformers overlap a reference ligand or shape query. Methods may score molecular volume alone or combine shape with chemical features. The screen does not require a target structure, but its ranking depends on the chosen reference, candidate conformers, alignment method, and score.
Shape screening tests a different hypothesis from two-dimensional fingerprint similarity: molecules with different graphs may occupy a comparable volume in a bioactive conformation. Adding donors, acceptors, aromatic regions, or charge features can reject overlays that match the envelope but present incompatible chemistry. Neither variant confirms a shared target or mechanism.
The reference is often an experimentally observed bound ligand, but a carefully supported bioactive conformation can also be used. Flexible candidates require broader conformer ensembles, increasing compute and the chance of implausible high-scoring overlays. A defensible shortlist therefore retains aligned coordinates, conformer provenance, strain or geometry review, and scaffold diversity.
When to use shape-based virtual screening
- A credible reference conformation is available. Use a bound ligand, experimentally supported pose, or carefully reviewed bioactive conformation as the shape query.
- Two-dimensional similarity is too restrictive. Search for compounds that preserve a three-dimensional envelope or feature arrangement despite having a different molecular graph.
- The target structure is unavailable or unsuitable. Rank compounds from ligand information when receptor-based docking cannot be justified.
Benefits of shape-based virtual screening
- Does not require a target structure. A reviewed bioactive ligand can provide the query even when the receptor structure or binding site is uncertain.
- Can retrieve different chemical scaffolds. Three-dimensional overlap can identify candidates that preserve an overall shape or feature pattern without sharing the same two-dimensional substructure.
- Supports rapid library triage. Shape comparisons can rank large prepared libraries before slower docking, simulation, or experimental follow-up.
- Produces inspectable alignments. Overlaying candidates with the reference makes the basis of a ranking easier to review than an unexplained aggregate score.
Primary limitations
- The reference conformation controls the search. An irrelevant or strained reference pose can favor the wrong molecular envelope and exclude useful candidates.
- Conformer generation can miss relevant geometries. A compound cannot receive a strong overlap score if the prepared conformer ensemble does not represent the geometry needed for alignment.
- Shape alone does not establish compatible chemistry. Two molecules can occupy similar volumes while presenting different electrostatic or interaction features.
- Flexible molecules create more ambiguity. Large conformer ensembles increase compute and can produce high-scoring overlays that depend on unlikely conformations.
- Experimental validation remains necessary. A shape match is a prioritization signal, not evidence of target binding, activity, selectivity, safety, or efficacy.
Shape-only, feature-aware, and multi-reference screening
The query design controls what “similar” means. Validate each strategy on chemistry that resembles the intended library rather than assuming the most detailed score is automatically the most useful.
- Shape-only overlap. Prioritize candidates that reproduce the reference volume when chemical-feature constraints would be premature or too restrictive.
- Shape and feature overlap. Combine volume with compatible donors, acceptors, aromatic regions, charge centers, or other typed features.
- Multi-reference screening. Use several justified ligands or conformations and preserve reference-specific ranks instead of hiding them behind an unexplained aggregate.
Shape-based virtual screening applications
Shape-based screening is useful for scaffold hopping, expanding around a bioactive ligand, and triaging libraries when a receptor structure is unavailable or unreliable. It can also provide a fast ligand-derived filter before a focused structure-based calculation.
A high overlap is least informative when the reference conformation is uncertain, candidates are highly flexible, or activity depends on directional interactions that the score omits. Review actual overlays and chemical features rather than selecting a shortlist from score values alone.
How to do shape-based virtual screening online
ProteinIQ currently provides a review workflow for aligned output from a dedicated shape-screening engine. The core overlay search remains external and should stay named in the run record.
- Choose the reference conformation. Record the ligand source, biological context, stereochemistry, protonation state, and reason this geometry represents the query.
- Standardize candidate structures. Preserve identifiers while resolving salts, stereochemistry, protonation, tautomers, duplicates, and invalid molecules.
- Generate suitable conformers. Select conformer limits and energy settings that recover relevant geometries for validation compounds without uncontrolled ensemble growth.
- Run the external overlay search. Apply the chosen shape-only or feature-aware method and export aligned SDF coordinates with reference identity, scores, and settings.
- Review aligned matches in ProteinIQ. Inspect geometry, properties, alerts, model applicability, and scaffold diversity while retaining rejected and failed candidates.
- Validate a diverse shortlist. Use an orthogonal target-aware method when available and test selected compounds in assays suited to the biological question.
How to interpret shape-screening results
Compare candidates within the same reference, conformer-generation policy, alignment method, and score definition. A score change after altering any of those inputs does not necessarily represent a meaningful change in biological plausibility.
Inspect whether the chosen overlay uses a strained or unusual conformer and whether key chemical features point in compatible directions. A diverse shortlist should represent several credible alignment hypotheses rather than many near-duplicate analogs of the top score.
How shape-based virtual screening works
A shape-based screen is a conformer comparison problem. Reference selection, candidate conformer generation, alignment, scoring, and diversity review all influence which compounds reach the shortlist.
- Choose the reference shape. Select a relevant ligand conformation and document its source, protonation state, stereochemistry, and biological context.
- Prepare candidate conformers. Standardize the candidate library, preserve identifiers, and generate a conformer ensemble that reflects the flexibility of each molecule.
- Align and score shapes. Overlay candidate conformers with the reference and rank them using the chosen shape and chemical-feature scoring method.
- Review chemistry and diversity. Inspect high-ranking overlays alongside molecular properties, liabilities, scaffold diversity, and unrealistic conformations.
- Shortlist and validate. Export a diverse set for orthogonal computational review and experiments suited to the target and assay question.
Inputs and outputs
Check formats before running, then inspect and download the result from every workflow step.
Inputs
- Reference ligand.
SDFMOL2SMILESUse a reviewed bioactive conformation when possible. Record its stereochemistry, protonation state, source, and biological context. - Candidate library.
SMILESSDFProvide standardized structures with stable identifiers so conformers, scores, and exclusions can be traced back to each compound. - Shape and feature settings. Define conformer limits, alignment behavior, shape-versus-feature weighting, and any score or diversity thresholds before screening.
Outputs
- Shape-ranked compounds.
CSVJSONRetain the best score, selected conformer, reference identity, and method settings for every ranked candidate. - Aligned conformers.
SDFMOL2Inspect and export candidate overlays in the coordinate frame of the reference query. - Property and diversity review.
CSVJSONCompare molecular properties, alerts, scaffold groups, and selection decisions alongside the shape ranking. - Run record.
LOGFILESKeep preparation failures, conformer settings, ranking parameters, and exported files connected to the screen.
Tools for shape-based virtual screening
Use these methods to prepare inputs, run the core analysis, inspect outputs, and validate the evidence described in this workflow.

ChEMBL Download
Retrieves known ligands and activity records for reference selection.

PubChem Download
Downloads reference compounds and candidate structures from PubChem.
Open Babel
Converts molecular formats and prepares three-dimensional coordinates.

Ligand fixer
Standardizes ligands, keeps the largest fragment, and generates 3D structures.

SMILES to SDF
Generates SDF structures from a SMILES candidate library.

SMILES to MOL2
Generates MOL2 structures with hydrogens and optional geometry optimization.

Molecular descriptors
Calculates properties and fingerprints for compound review and diversity checks.

Veber's rule
Reviews flexibility and polar surface area for shortlisted compounds.

Lipinski's rule of 5
Reports rule-of-five properties without replacing biological validation.

Lead-likeness filter
Reviews candidates against lead-likeness property ranges.

ADMET-AI
Adds predicted ADMET endpoints as a separate shortlist triage layer.

Admetica
Provides an independent set of predicted ADMET properties for review.
Other small-molecule discovery workflows
Compare related approaches based on the molecular system, available evidence, required inputs, and decision you need to support.
Structure-based virtual screening
Uses a three-dimensional target to generate and score candidate binding poses, often alongside pocket, property, and pose-quality review.
Ligand-based virtual screening
Ranks compounds using similarity, molecular fingerprints, pharmacophores, or learned features derived from known ligands.
Pharmacophore-based virtual screening
Searches for compounds that match a three-dimensional arrangement of interaction features such as donors, acceptors, aromatic regions, hydrophobic regions, and charge centers.
High-throughput virtual screening
Applies staged filtering, batching, and compute planning to screen much larger libraries while keeping throughput and failure handling explicit.
Inverse virtual screening
Evaluates one compound against many potential targets to generate hypotheses about intended targets, off-targets, selectivity, or repurposing opportunities.
Frequently asked questions
Prefer a ligand conformation supported by an experimental complex or strong mechanistic evidence. If several credible conformations exist, screen them separately or define a transparent multi-reference strategy instead of assuming one pose represents every active chemotype.
The useful number depends on molecular flexibility, library size, the conformer generator, and available compute. Test the settings on compounds with relevant known conformations and inspect whether the ensemble recovers them before scaling the screen.
Chemical-feature scoring can reduce overlays that match volume but present incompatible interaction features. The weighting should be chosen before the full screen and tested against a representative validation set.
It can retrieve molecules with different two-dimensional structures that occupy a similar three-dimensional envelope. Whether those candidates preserve activity depends on their conformations, interaction chemistry, and the target context.
Inspect the actual overlays, conformer strain, stereochemistry, feature alignment, property profile, and scaffold diversity. Follow with an orthogonal method and experimental assays appropriate to the biological question.
One published 2025 service offer priced a 3D shape-based screen of 1.76 million compounds at $5,000, including analysis, a pharmacophore-similarity report, and a curated set of 200 compounds. It is a useful reference point rather than a standing market rate.
Current commercial platforms commonly quote licenses or projects individually. Price depends on library size, conformers per molecule, reference count, 3D alignment and feature settings, and manual overlay review.
ProteinIQ self-service is available through Plus at $29 per month for academic work and Pro at $99 per month for commercial work, with credits quoted before the workflow launches. Done-for-you shape screening is priced to the requested preparation and review.
Start with a workflow you can inspect and edit
Add your inputs, review the settings, and keep every structure, score, table, and file connected to the step that produced it.